Clinical Trials in New York

Showing 14501-14520 of 22,668 trials

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

NCT03893890

This is a Phase 2b, rollover, long-term study to evaluate the safety and duration of efficacy of EN3835 in the treatment of women with EFP. Subjects who participated in and completed studies EN3835-201 and EN3835-202 and had composite improvement of at least 2 levels on both the CR-PCSS and PR-PCSS in study EN3835-201 will be eligible for this study.

Edematous Fibrosclerotic Panniculopathy

Endo Pharmaceuticals8 participantsStarted Mar 2019

Clearwater, Florida, United States • Coral Gables, Florida, United States • Washington, Missouri, United States +2 more locations

COMPLETEDPhase 1< 1 mile

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT01281852

This phase I clinical trial studies the side effects and best dose of veliparib when given together with paclitaxel and cisplatin and to see how well they work in treating patients with cervical cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment or that has come back. Drugs used in chemotherapy, such as paclitaxel and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Veliparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving more than one drug (combination chemotherapy) and giving chemotherapy together with veliparib may kill more tumor cells.

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more

National Cancer Institute (NCI)37 participantsStarted Mar 2011

Los Angeles, California, United States • Augusta, Georgia, United States • Chicago, Illinois, United States +22 more locations

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Find Trials by Condition in New York

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy

Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma

Exercise and Transcranial Magnetic Stimulation: Increasing Brain Plasticity in Parkinson's Disease

Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients

Study Assessing Double-masked Uveitis Treatment

Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program

Fetal ST Segment and T Wave Analysis in Labor

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Comparative Effectiveness of Pregnancy Failure Management Regimens

Barriers to Mental Healthcare Utilization in Parkinson's Disease

Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD

Post Market Evaluation of Aer-O-Scope Visualization